Literature DB >> 7969977

Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study.

G J Dal Pan1, J D Glass, J C McArthur.   

Abstract

To determine the clinical correlates of HIV-1-associated vacuolar myelopathy (VM), we designed a case-control study based on 215 AIDS autopsies in which we examined the spinal cord. We defined a case as an individual dying with AIDS and with VM present at autopsy; we defined a control as an individual dying with AIDS without VM. VM was found in 100 of 215 (46.5%) autopsies, with no apparent temporal trends. A higher number of AIDS-defining illnesses was strongly associated with the likelihood of VM (trend chi-square = 26.52, p < 0.001). Systemic infection with Mycobacterium avium-intracellulare and Pneumocystis carinii pneumonia were each associated with the pathologic findings of VM in both univariate and multivariate models. In the brain, multinucleated giant cells were detected in more cases than in controls (odds ratio = 3.68, 95% CI = 1.73 to 7.47, p < 0.001). The clinical features of HIV-1 dementia were not associated with VM; in contrast, predominantly sensory neuropathy was more common in VM cases than in controls (odds ratio = 5.00, 95% CI = 1.35 to 18.5, p < 0.05). Fifty-six cases with VM had detailed neurologic evaluations, but only 15 (26.8%) had signs and symptoms of myelopathy. The presence of symptomatic myelopathy was related to the pathologic severity: none of 17 cases with grade 1, five of 26 with grade 2, and 10 of 13 with grade 3 had clinical features of myelopathy (trend chi-square = 21.16, p < 0.005). VM is a common neuropathologic finding that is frequently unrecognized during life. The association with the number of systemic illnesses, M avium-intracellulare infection, and P carinii pneumonia suggests that the development of VM is related to the severity of immunosuppression.

Entities:  

Mesh:

Year:  1994        PMID: 7969977     DOI: 10.1212/wnl.44.11.2159

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.

Authors:  Katia Cikurel; Lauren Schiff; David M Simpson
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

3.  HIV-Associated Vacuolar Encephalomyelopathy.

Authors:  Gregory R Madden; Molly E Fleece; Akriti Gupta; M Beatriz S Lopes; Scott K Heysell; Christopher J Arnold; Brian Wispelwey
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

4.  Diagnostic challenges in vacuolar myelopathy: a didactic case report.

Authors:  Florian Ernst; Fritz Klausner; Waltraud Kleindienst; Heinrich Bartsch; Ninon Taylor; Eugen Trinka
Journal:  Spinal Cord Ser Cases       Date:  2016-09-15

5.  Neuroinflammation and virus replication in the spinal cord of simian immunodeficiency virus-infected macaques.

Authors:  Lisa M Mangus; Jamie L Dorsey; Victoria A Laast; Peter Hauer; Suzanne E Queen; Robert J Adams; Justin C McArthur; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

6.  MR findings in AIDS-associated myelopathy.

Authors:  J Chong; A Di Rocco; M Tagliati; F Danisi; D M Simpson; S W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

Review 7.  Update of HIV-Associated Sensory Neuropathies.

Authors:  Angela Aziz-Donnelly; Taylor B Harrison
Journal:  Curr Treat Options Neurol       Date:  2017-08-31       Impact factor: 3.598

8.  HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.

Authors:  Lauren N Bowen; Richa Tyagi; Wenxue Li; Tariq Alfahad; Bryan Smith; Mary Wright; Elyse J Singer; Avindra Nath
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

9.  Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro.

Authors:  Fatiha Radja; Denis G Kay; Steffen Albrecht; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 10.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.